YTHDF1 deficiency could affect the translation efficiency of CDK2, CDK4 and cyclin D1 and inhibit NSCLC cell proliferation and lung squamous cell carcinoma progression, while high YTHDF1 expression was associated with better clinical outcome (Shi et al., 2019). This evidence concerns the gene YTHDF1 and squamous cell lung carcinoma.